caa a22 4500 475773705 CHVBK 20180406123624.0 cr unu---uuuuu 170329e20000601xx s 000 0 eng 10.1023/A:1007174213087 doi (NATIONALLICENCE)springer-10.1023/A:1007174213087 Three dimensional conformal radiotherapy in patients with T2a-b, N0, M0 prostatic carcinoma [Elektronische Daten] [Cengiz Kurtman, Binnaz Çelebioğlu, Orhan Göğüş, Meltem Andrieu] The current study was undertaken to evaluate the Prostate Specific Antigen (PSA) relapse free survival and the prognostic factors in a total of 38 patients with stages of T2a-b, N0, M0 prostate carcinoma treated with three-dimensional conformal radiotherapy (3D-CRT). Mean 69.63 Gy was given with 3D-CRT, the mean follow up time was 13.89 months, and the mean prebiopsied PSA level was 25.12 ng/ml. The 2-year PSA relapse free survival was 47.37% for the entire group. The 2-year PSA relapse free survival rates were 100% and 44.74% for the patients with Gleason score ≤ 7 and greater than 7 (p ≤ 0.05). Patients with prebiopsied PSA level ≤ 10 ng/ml and the stages of T2a or T2b did not show any significant differences (p ≥ 0.05). Although the few case number and short term follow up, in this study 3D-CRT was a new effective technique to prostate cancer for our institutes and the Gleason score was important predictor of PSA relapse free survival. Kluwer Academic Publishers, 2000 Prostatic carcinoma nationallicence Radiotherapy nationallicence Kurtman Cengiz Department of Radiation Oncology, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey aut Çelebioğlu Binnaz Department of Radiation Oncology, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey aut Göğüş Orhan Department of Urology, İbn-i Sina Hospital, Ankara University Medical Faculty, Ankara, Turkey aut Andrieu Meltem Department of Radiation Oncology, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey aut International Urology and Nephrology Kluwer Academic Publishers 32/2(2000-06-01), 275-278 0301-1623 32:2<275 2000 32 11255 https://doi.org/10.1023/A:1007174213087 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1023/A:1007174213087 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Kurtman Cengiz Department of Radiation Oncology, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey aut NATIONALLICENCE 700 1- Çelebioğlu Binnaz Department of Radiation Oncology, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey aut NATIONALLICENCE 700 1- Göğüş Orhan Department of Urology, İbn-i Sina Hospital, Ankara University Medical Faculty, Ankara, Turkey aut NATIONALLICENCE 700 1- Andrieu Meltem Department of Radiation Oncology, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey aut NATIONALLICENCE 773 0- International Urology and Nephrology Kluwer Academic Publishers 32/2(2000-06-01), 275-278 0301-1623 32:2<275 2000 32 11255 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer